Journal profile · Oncology
Onkologie
ISSN 0378-584X · eISSN 2731-7234 · Springer Nature · SWITZERLAND · Bimonthly · Founded 1978
Onkologie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.17; hybrid open access; review about 3 months (community reports); community-reported acceptance: about 75%; 174 articles a year; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Onkologie is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 38.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance16.8%
- Human auditory perception and evaluationEngineering14.4%
- Educational Robotics and EngineeringComputer Science6.9%
- Lung Cancer Treatments and MutationsMedicine5.1%
- Medical and Health Sciences ResearchMedicine4.9%
- Cancer Treatment and PharmacologyMedicine4.7%
- Clinical practice guidelines implementationMedicine3.5%
- German Literature and Culture StudiesArts and Humanities3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.17LetPub ·
- CiteScore 2026-06
- 0.3LetPub ·
- SJR 2026-06
- 0.13LetPub ·
- SNIP 2026-06
- 0.1LetPub ·
- h-index
- 3LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 364OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 50%LetPub ·
- Share of gold OA articles
- 11.69%LetPub ·
Volume
- Articles per year
- 174LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- SWITZERLAND
- Frequency
- Bimonthly
- Founded
- 1978
- ISSN
- 0378-584X
- Electronic ISSN
- 2731-7234
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Onkologie
What CAS zone is Onkologie in?
In the 2025 upgraded edition of the CAS Journal Ranking, Onkologie is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Onkologie?
The latest impact factor listed by LetPub is 0.17; CiteScore 0.3, h-index 37.
How long does peer review take at Onkologie?
Authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Onkologie?
According to LetPub and DOAJ records, Onkologie is indexed in SCIE and Scopus.
Is Onkologie open access, and what is the APC?
Onkologie is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .